Alex Bajamonde

TL;DR: The addition of trastuzumab to chemotherapy was associated with a longer time to disease progression, a higher rate of objective response, a longer duration of response, and a lower rate of death at 1 year.

TL;DR: The VIVA (Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis) trial as discussed by the authors was designed to evaluate the safety and efficacy of intracoronary and intravenous infusions of rhVEGF.

TL;DR: Her2 status determined by CTA-IHC and FISH are significantly correlated; however, differences between these two assays can a ect patient selection for trastuzumab therapy.

TL;DR: Understanding Gene Alterations in Human Breast Cancer Gene alterations play an important role in the origin and pathogenesis of human breast cancer and are hypothesized to occur by an accumulated series of genetic and phenotypic changes in pathways regulating cell growth.

TL;DR: Recombinant interferon gamma 1b has only minimal efficacy in the treatment of metastatic renal cell carcinoma, and Pretreatment variables associated with increased survival were male sex, higher Karnofsky performance status, higher hemoglobin, and low LDH.